杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/06/02 | 1,749 | 1,773 | 1,747 | 1,773 | +30 | +1.7% | 91,800 |
2023/06/01 | 1,750 | 1,762 | 1,740 | 1,743 | +12 | +0.7% | 104,000 |
2023/05/31 | 1,751 | 1,760 | 1,718 | 1,731 | -33 | -1.9% | 376,300 |
2023/05/30 | 1,782 | 1,782 | 1,756 | 1,764 | -22 | -1.2% | 60,700 |
2023/05/29 | 1,780 | 1,799 | 1,769 | 1,786 | +27 | +1.5% | 82,300 |
2023/05/26 | 1,793 | 1,793 | 1,758 | 1,759 | -36 | -2% | 72,100 |
2023/05/25 | 1,786 | 1,808 | 1,781 | 1,795 | +9 | +0.5% | 127,300 |
2023/05/24 | 1,795 | 1,796 | 1,782 | 1,786 | -4 | -0.2% | 104,100 |
2023/05/23 | 1,784 | 1,794 | 1,779 | 1,790 | +14 | +0.8% | 177,900 |
2023/05/22 | 1,747 | 1,778 | 1,746 | 1,776 | +35 | +2% | 66,800 |
2023/05/19 | 1,755 | 1,755 | 1,735 | 1,741 | -4 | -0.2% | 66,300 |
2023/05/18 | 1,770 | 1,770 | 1,742 | 1,745 | -17 | -1% | 64,300 |
2023/05/17 | 1,763 | 1,769 | 1,756 | 1,762 | -4 | -0.2% | 57,800 |
2023/05/16 | 1,750 | 1,766 | 1,745 | 1,766 | +22 | +1.3% | 89,400 |
2023/05/15 | 1,740 | 1,749 | 1,737 | 1,744 | +11 | +0.6% | 64,100 |
2023/05/12 | 1,730 | 1,740 | 1,723 | 1,733 | +13 | +0.8% | 88,100 |
2023/05/11 | 1,732 | 1,733 | 1,718 | 1,720 | -22 | -1.3% | 46,300 |
2023/05/10 | 1,753 | 1,753 | 1,739 | 1,742 | -14 | -0.8% | 56,000 |
2023/05/09 | 1,759 | 1,759 | 1,752 | 1,756 | +7 | +0.4% | 50,800 |
2023/05/08 | 1,741 | 1,761 | 1,741 | 1,749 | +10 | +0.6% | 58,500 |
2023/05/02 | 1,760 | 1,763 | 1,733 | 1,739 | -16 | -0.9% | 65,600 |
2023/05/01 | 1,755 | 1,761 | 1,748 | 1,755 | +8 | +0.5% | 64,000 |
2023/04/28 | 1,748 | 1,752 | 1,740 | 1,747 | +21 | +1.2% | 77,400 |
2023/04/27 | 1,724 | 1,732 | 1,718 | 1,726 | +2 | +0.1% | 56,800 |
2023/04/26 | 1,738 | 1,738 | 1,720 | 1,724 | -17 | -1% | 46,500 |
2023/04/25 | 1,733 | 1,748 | 1,733 | 1,741 | +15 | +0.9% | 94,000 |
2023/04/24 | 1,723 | 1,735 | 1,718 | 1,726 | +3 | +0.2% | 110,600 |
2023/04/21 | 1,729 | 1,733 | 1,722 | 1,723 | -8 | -0.5% | 53,100 |
2023/04/20 | 1,722 | 1,735 | 1,722 | 1,731 | +2 | +0.1% | 57,400 |
2023/04/19 | 1,735 | 1,735 | 1,724 | 1,729 | -11 | -0.6% | 43,400 |
2023/04/18 | 1,729 | 1,742 | 1,729 | 1,740 | +18 | +1% | 52,300 |
2023/04/17 | 1,735 | 1,735 | 1,716 | 1,722 | -12 | -0.7% | 37,600 |
2023/04/14 | 1,726 | 1,735 | 1,723 | 1,734 | +20 | +1.2% | 84,700 |
2023/04/13 | 1,709 | 1,717 | 1,705 | 1,714 | +8 | +0.5% | 46,600 |
2023/04/12 | 1,722 | 1,726 | 1,705 | 1,706 | -11 | -0.6% | 45,000 |
2023/04/11 | 1,719 | 1,722 | 1,704 | 1,717 | +6 | +0.4% | 89,200 |
2023/04/10 | 1,715 | 1,718 | 1,702 | 1,711 | +3 | +0.2% | 32,600 |
2023/04/07 | 1,696 | 1,715 | 1,696 | 1,708 | +9 | +0.5% | 57,000 |
2023/04/06 | 1,697 | 1,712 | 1,694 | 1,699 | -4 | -0.2% | 81,300 |
2023/04/05 | 1,721 | 1,721 | 1,701 | 1,703 | -24 | -1.4% | 65,800 |
2023/04/04 | 1,725 | 1,732 | 1,718 | 1,727 | +6 | +0.3% | 86,400 |
2023/04/03 | 1,723 | 1,732 | 1,714 | 1,721 | +17 | +1% | 63,800 |
2023/03/31 | 1,693 | 1,709 | 1,692 | 1,704 | +11 | +0.6% | 68,100 |
2023/03/30 | 1,703 | 1,703 | 1,690 | 1,693 | -30 | -1.7% | 73,000 |
2023/03/29 | 1,719 | 1,724 | 1,710 | 1,723 | +13 | +0.8% | 127,200 |
2023/03/28 | 1,712 | 1,714 | 1,707 | 1,710 | +1 | +0.1% | 54,000 |
2023/03/27 | 1,712 | 1,717 | 1,703 | 1,709 | +12 | +0.7% | 83,400 |
2023/03/24 | 1,696 | 1,703 | 1,689 | 1,697 | +1 | +0.1% | 69,800 |
2023/03/23 | 1,680 | 1,697 | 1,670 | 1,696 | +13 | +0.8% | 108,400 |
2023/03/22 | 1,710 | 1,710 | 1,682 | 1,683 | -2 | -0.1% | 88,700 |
451~
500
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 143,100円 | +3.2% | +4.5% | 3.63% | 16.44倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
サンバイオ | 162,700円 | - | - | 0.00% | - | 75.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
持田薬 | 301,500円 | +3.0% | +27.5% | 2.65% | 19.09倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 174,100円 | +21.7% | +999.9% | 0.00% | 7.25倍 | 2.40倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
栄研化 | 213,600円 | +0.4% | -8.4% | 2.48% | 27.42倍 | 1.55倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム